Stryker and CMR Surgical announce strategic alliance for robotic-assisted surgery

Stryker will make an approximately $400 million preferred equity investment in CMR Surgical, with an exclusive option to acquire 100% of CMR Surgical in the future. Stryker will serve as the exclusive U.S. sales agent for the Versius surgical robotic portfolio.

“Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical to support future innovation and global commercialization of the Versius portfolio.”stryker.com

• 1 source
• stryker.comStryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery | StrykerOct 12, 2026

Summarized from public sources; check the original articles before acting on it.